Design and synthesis of further simplified pyripyropene A based ACAT2 selective inhibitors

  • Yi Liu
  • , Xiaowei Zhang
  • , Yang Zhan
  • , Boliang Li
  • , Wei Lu
  • , Fajun Nan*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Acyl-coenzyme A: cholesterol acyltransferases (ACATs) play the significant role in the formation of cholesterol esters. One form of this enzyme is ACAT2, which not only regulates the balance of cholesterol metabolism in cells but also participates in the “escape” mechanism of hepatocellular carcinoma (HCC) cells. The natural product pyripyropene A (PPPA) and its analogs are the only chemical ACAT2-specific inhibitors. To develop simpler analogs and endeavor to remove a portion of multichiral centers and enrich a variety of analogs, new PPPA analogs are creatively designed and synthesized based on previous work. Among these new analogs, 7a and 9f show better activity and selective inhibition of ACAT2 compared with PPPA. These results will provide a new future for potential therapeutic use in atherosclerosis and HCC.

Original languageEnglish
Pages (from-to)1819-1825
Number of pages7
JournalTetrahedron
Volume75
Issue number12
DOIs
StatePublished - 22 Mar 2019

Keywords

  • Acyl-coenzyme A
  • Cholesterol acyltransferase 2 selective inhibitors
  • Pyripyropene A
  • Simplified structure

Fingerprint

Dive into the research topics of 'Design and synthesis of further simplified pyripyropene A based ACAT2 selective inhibitors'. Together they form a unique fingerprint.

Cite this